BMO Capital lowered the firm’s price target on Accelerant (ARX) to $22.50 from $34 and keeps an Outperform rating on the shares. The firm is adjusting its valuation model, moving to a sum-of-the-parts ...
Morgan Stanley lowered the firm’s price target on Accelerant (ARX) to $17 from $18 and keeps an Equal Weight rating on the shares. The firm updated models in the insurance space post the Q3 reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback